Separate terms with OR to return results that match either term.
 
Clear All

9,635 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status (Descending)
70518-1585-02 70518-1585 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Oral Feb. 3, 2021 March 9, 2021 In Use
70518-2023-00 70518-2023 Methylprednisolone sodium succinate SOLU-MEDROL 125.0 mg/2mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous April 15, 2019 In Use
70518-2023-01 70518-2023 Methylprednisolone sodium succinate SOLU-MEDROL 125.0 mg/2mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous April 15, 2019 In Use
70518-2023-02 70518-2023 Methylprednisolone sodium succinate SOLU-MEDROL 125.0 mg/2mL Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Intramuscular, Intravenous Aug. 27, 2021 In Use
71205-0403-05 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral March 19, 2020 Aug. 31, 2023 In Use
71205-0403-06 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug. 18, 2021 Aug. 31, 2023 In Use
71205-0403-07 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Aug. 13, 2020 Aug. 31, 2023 In Use
71205-0403-10 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral April 23, 2021 Aug. 31, 2023 In Use
71205-0403-12 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 17, 2020 Aug. 31, 2023 In Use
71205-0403-30 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 17, 2020 Aug. 31, 2023 In Use
71205-0403-60 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 17, 2020 Aug. 31, 2023 In Use
71205-0403-90 71205-0403 Prednisone Prednisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Feb. 17, 2020 Aug. 31, 2023 In Use
72143-0231-30 72143-0231 ISOTRETINOIN ACCUTANE 10.0 mg/1 Hormonal Therapy Immunomodulator Retinoic Acid Derivative Oral Jan. 11, 2021 Sept. 30, 2023 In Use
72143-0233-30 72143-0233 ISOTRETINOIN ACCUTANE 30.0 mg/1 Hormonal Therapy Immunomodulator Retinoic Acid Derivative Oral Jan. 11, 2021 Jan. 31, 2024 In Use
72143-0234-30 72143-0234 ISOTRETINOIN ACCUTANE 40.0 mg/1 Hormonal Therapy Immunomodulator Retinoic Acid Derivative Oral Jan. 11, 2021 Dec. 31, 2023 In Use
76388-0635-25 76388-0635 Chlorambucil Leukeran 2.0 mg/1 Chemotherapy Alkylating Agent Nitrogen Mustard Oral Feb. 13, 1985 Sept. 30, 2023 In Use
76388-0635-50 76388-0635 Chlorambucil Leukeran 2.0 mg/1 Chemotherapy Alkylating Agent Nitrogen Mustard Oral Feb. 13, 1985 Oct. 31, 2017 In Use
76388-0713-25 76388-0713 Busulfan Myleran 2.0 mg/1 Chemotherapy Alkylating Agent Alkylsulfonate Oral March 21, 1985 June 30, 2023 In Use
76388-0880-25 76388-0880 Thioguanine Tabloid 40.0 mg/1 Chemotherapy Antimetabolite Purine Analog Oral March 12, 2013 March 31, 2025 In Use
00078-0683-06 00078-0683 Nelarabine Arranon 5.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Oct. 5, 2016 In Use
00078-0683-61 00078-0683 Nelarabine Arranon 5.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Aug. 2, 2019 In Use
65162-0843-06 65162-0843 Capecitabine Capecitabine 150.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral March 10, 2017 Feb. 1, 2024 In Use
65162-0844-06 65162-0844 Capecitabine Capecitabine 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral March 10, 2017 Feb. 1, 2024 In Use
65162-0844-16 65162-0844 Capecitabine Capecitabine 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral March 10, 2017 Feb. 1, 2024 In Use
65162-0844-50 65162-0844 Capecitabine Capecitabine 500.0 mg/1 Chemotherapy Antimetabolite Pyrimidine Analog Oral March 10, 2017 Feb. 1, 2024 In Use

Found 9,635 results in 11 millisecondsExport these results